Molecular Templates, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

NET LOSS PER COMMON SHARE (Tables)

NET LOSS PER COMMON SHARE (Tables)

12 Months Ended

Dec. 31, 2012

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):


	Years Ended December 31,
	2012			2011			2010
Numerator:
Net loss	$	(71,135	)	$	(25,653	)	$	(18,682	)

Denominator:
Weighted-average number of common shares outstanding		54,219			45,900			33,654

Net loss per share:
Basic	$	(1.31	)	$	(0.56	)	$	(0.56	)

Diluted	$	(1.31	)	$	(0.56	)	$	(0.56	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Share

The following warrants, outstanding options, common stock subject to repurchase and purchase rights under the Company’s ESPP were excluded from the computation of diluted net loss per common share for the periods presented because including them would have had an antidilutive effect (in thousands):


	December 31,
	2012		2011		2010
Shares issuable upon exercise of warrants		11,583		16,643		10,918
Shares issuable upon exercise of stock options		5,099		3,672		2,746
Shares issuable related to the ESPP		79		70		61